1. Home >
  2. Morgan Stanley Private Equity Asia Acquires Jeonju Paper

M&A Deal Summary

Morgan Stanley Private Equity Asia Acquires Jeonju Paper

On January 1, 2008, private equity firm Morgan Stanley Private Equity Asia acquired forest products company Jeonju Paper

Acquisition Highlights
  • This is Morgan Stanley Private Equity Asia’s 1st transaction in the Forest Products sector.
  • This is Morgan Stanley Private Equity Asia’s 1st transaction in South Korea.

M&A Deal Summary
Date 2008-01-01
Target Jeonju Paper
Sector Forest Products
Buyer(s) Morgan Stanley Private Equity Asia
Deal Type Buyout (LBO, MBO, MBI)

Target

Jeonju Paper

Seoul, South Korea
Jeonju Paper is a manufacturer of newsprint and specialized paper in South Korea, and one of the largest newsprint exporters in Asia. Jeonju Paper is based in Seoul, South Korea.

Search 205,036 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Morgan Stanley Private Equity Asia

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1993
Size Large
Type Sector Agnostic
DESCRIPTION

Morgan Stanley Private Equity Asia is a direct investment affiliate of Morgan Stanley that looks to acquire minority investments in companies with substantial business operations throughout Asia. The Unit has a preference for fast-growing businesses with strong brands and sustainable competitive advantages. In addition to minority deals, the Firm will also consider select control situations. Morgan Stanley Private Equity Asia was formed in 1993 and is headquartered in Hong Kong.

DEAL STATS #
Overall 3 of 35
Sector (Forest Products) 1 of 1
Type (Buyout (LBO, MBO, MBI)) 1 of 6
Country (South Korea) 1 of 3
Year (2008) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-12-01 Asia Capital Reinsurance Group

Singapore, Singapore

Asia Capital Reinsurance Group is a non-life reinsurance group dedicated to serving clients in Asia. ACR focuses on large risk underwriting in specialist lines, including aviation, marine, energy, property, engineering, and casualty. ACR was founded in 2006 and is based in Singapore.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-01 Buchang Pharmaceutical

Heze, China

Buchang Pharmaceutical is principally engaged in R&D, production and sales of traditional Chinese medicines (”TCM”) in China with a focus on the cardiovascular diseases therapeutic area. Buchang produces branded, patented, and mostly prescription-only TCM in different delivery formats. Buchang’s products can found in 15,000 hospitals and 150,000 drug stores across China and have been used by more than 50 million patients. Buchang Pharmaceutical was founded in 1993 and is based in Heze, China.

Buy -
Mergr

Product

Company

Legal